<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jaaskelainen T</submitter><funding>Novo Nordisk Fonden</funding><pagination>14616</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6168522</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(1)</volume><pubmed_abstract>Preeclampsia (PE) is a complex pregnancy disorder. It is not extensively known how the metabolic alterations of PE women contribute to the metabolism of newborn. We applied liquid chromatography-mass spectrometry (LC-MS) based non-targeted metabolomics to determine whether the metabolic profile of plasma from umbilical cord differs between infants born to PE and non-PE pregnancies in the FINNPEC study. Cord plasma was available from 42 newborns born from PE and 53 from non-PE pregnancies. 133 molecular features differed between PE and non-PE newborns after correction for multiple testing. Decreased levels of 4-pyridoxic acid were observed in the cord plasma samples of PE newborns when compared to non-PE newborns. Compounds representing following areas of metabolism were increased in the cord plasma of PE newborns: urea and creatine metabolism; carnitine biosynthesis and acylcarnitines; putrescine metabolites; tryptophan metabolism and phosphatidylcholines. To our knowledge, this study is the first one to apply LC-MS based metabolomics in cord plasma of PE newborns. We demonstrate that this strategy provides a global picture of the widespread metabolic alterations associated with PE and particularly the elevated levels of carnitine precursors and trimethylated compounds appear to be associated with PE at birth.</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>A Non-Targeted LC-MS Profiling Reveals Elevated Levels of Carnitine Precursors and Trimethylated Compounds in the Cord Plasma of Pre-Eclamptic Infants.</pubmed_title><pmcid>PMC6168522</pmcid><funding_grant_id>NNF12OC1016374</funding_grant_id><funding_grant_id>NNF15OC0016362</funding_grant_id><pubmed_authors>Kajantie E</pubmed_authors><pubmed_authors>Kivinen K</pubmed_authors><pubmed_authors>Karkkainen O</pubmed_authors><pubmed_authors>Heinonen S</pubmed_authors><pubmed_authors>Auriola S</pubmed_authors><pubmed_authors>Pouta A</pubmed_authors><pubmed_authors>Litonius K</pubmed_authors><pubmed_authors>Hanhineva K</pubmed_authors><pubmed_authors>Laivuori H</pubmed_authors><pubmed_authors>Kere J</pubmed_authors><pubmed_authors>Lehtonen M</pubmed_authors><pubmed_authors>Jokkala J</pubmed_authors><pubmed_authors>FINNPEC</pubmed_authors><pubmed_authors>Jaaskelainen T</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Non-Targeted LC-MS Profiling Reveals Elevated Levels of Carnitine Precursors and Trimethylated Compounds in the Cord Plasma of Pre-Eclamptic Infants.</name><description>Preeclampsia (PE) is a complex pregnancy disorder. It is not extensively known how the metabolic alterations of PE women contribute to the metabolism of newborn. We applied liquid chromatography-mass spectrometry (LC-MS) based non-targeted metabolomics to determine whether the metabolic profile of plasma from umbilical cord differs between infants born to PE and non-PE pregnancies in the FINNPEC study. Cord plasma was available from 42 newborns born from PE and 53 from non-PE pregnancies. 133 molecular features differed between PE and non-PE newborns after correction for multiple testing. Decreased levels of 4-pyridoxic acid were observed in the cord plasma samples of PE newborns when compared to non-PE newborns. Compounds representing following areas of metabolism were increased in the cord plasma of PE newborns: urea and creatine metabolism; carnitine biosynthesis and acylcarnitines; putrescine metabolites; tryptophan metabolism and phosphatidylcholines. To our knowledge, this study is the first one to apply LC-MS based metabolomics in cord plasma of PE newborns. We demonstrate that this strategy provides a global picture of the widespread metabolic alterations associated with PE and particularly the elevated levels of carnitine precursors and trimethylated compounds appear to be associated with PE at birth.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Oct</publication><modification>2026-05-06T20:17:27.667Z</modification><creation>2019-03-26T23:58:38Z</creation></dates><accession>S-EPMC6168522</accession><cross_references><pubmed>30279541</pubmed><doi>10.1038/s41598-018-32804-5</doi></cross_references></HashMap>